Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Individually tailored immunosuppression: is there a role for biomarkers?

Brandhorst G, Oellerich M, Brunet M, Kowalski R, Vinks A, Wallemacq P.

Clin Chem. 2011 Mar;57(3):376-81. doi: 10.1373/clinchem.2010.159871. Epub 2011 Jan 12. No abstract available.

PMID:
21228253
[PubMed - indexed for MEDLINE]
Free Article
2.

Personalized immunosuppressive therapy in pediatric heart transplantation: Progress, pitfalls and promises.

Xie HG.

Pharmacol Ther. 2010 May;126(2):146-58. doi: 10.1016/j.pharmthera.2010.01.007. Epub 2010 Feb 11. Review.

PMID:
20153366
[PubMed - indexed for MEDLINE]
3.

Biomarkers as a tool for management of immunosuppression in transplant patients.

Wieland E, Olbricht CJ, Süsal C, Gurragchaa P, Böhler T, Israeli M, Sommerer C, Budde K, Hartmann B, Shipkova M, Oellerich M.

Ther Drug Monit. 2010 Oct;32(5):560-72. doi: 10.1097/FTD.0b013e3181efb3d2. Review.

PMID:
20814352
[PubMed - indexed for MEDLINE]
4.

Review: Pharmacodynamic monitoring of immunosuppression in kidney transplantation.

Barraclough KA, Staatz CE, Isbel NM, McTaggart SJ.

Nephrology (Carlton). 2010 Aug;15(5):522-32. doi: 10.1111/j.1440-1797.2010.01349.x. Review.

PMID:
20649871
[PubMed - indexed for MEDLINE]
5.

Developing a tool for noninvasive monitoring of renal allografts.

Schaub S, Wilkins JA, Rush D, Nickerson P.

Expert Rev Proteomics. 2006 Oct;3(5):497-509. Review.

PMID:
17078764
[PubMed - indexed for MEDLINE]
6.

[The relevance of biomarkers for personalised medicine].

Großhennig A, Benda N, Koch A.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Nov;56(11):1480-8. doi: 10.1007/s00103-013-1828-9. German.

PMID:
24084852
[PubMed - indexed for MEDLINE]
7.

Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies.

Miossec P, Verweij CL, Klareskog L, Pitzalis C, Barton A, Lekkerkerker F, Reiter S, Laslop A, Breedveld F, Abadie E, Flamion B, Dere W, Mpofu S, Goel N, Ethgen D, Mitlak B, Ormarsdóttir S, Rao R, Tsouderos Y, Reginster JY; Group for Respect of Ethics and Excellence in Science (GREES).

Ann Rheum Dis. 2011 Oct;70(10):1713-8. doi: 10.1136/ard.2011.154252. Epub 2011 Jul 22. Review.

PMID:
21784723
[PubMed - indexed for MEDLINE]
8.

Quantification of T-cell proliferation for individualizing immunosuppressive therapy for transplantation patients.

Ohdan H.

Clin Pharmacol Ther. 2010 Jan;87(1):23-6. doi: 10.1038/clpt.2009.171. Review.

PMID:
20019698
[PubMed - indexed for MEDLINE]
9.

Target enzyme activity as a biomarker for immunosuppression.

Glander P, Budde K.

Ther Drug Monit. 2010 Jun;32(3):257-60. doi: 10.1097/FTD.0b013e3181ddd7b3.

PMID:
20431505
[PubMed - indexed for MEDLINE]
10.

Prospects for personalized immunosuppression: pharmacologic tools--a review.

Del Tacca M.

Transplant Proc. 2004 Apr;36(3):687-9. Review.

PMID:
15110631
[PubMed - indexed for MEDLINE]
11.

Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy.

Taylor AL, Watson CJ, Bradley JA.

Crit Rev Oncol Hematol. 2005 Oct;56(1):23-46. Review.

PMID:
16039869
[PubMed - indexed for MEDLINE]
12.

Applications of molecular imaging in drug discovery and development process.

Ahn BC.

Curr Pharm Biotechnol. 2011 Apr;12(4):459-68.

PMID:
21342108
[PubMed - indexed for MEDLINE]
13.

Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid.

Shaw LM, Korecka M, van Breeman R, Nowak I, Brayman KL.

Clin Biochem. 1998 Jul;31(5):323-8. Review. No abstract available.

PMID:
9721429
[PubMed - indexed for MEDLINE]
14.

Biomarkers: the link between therapeutic drug monitoring and pharmacodynamics.

Oellerich M, Barten MJ, Armstrong VW.

Ther Drug Monit. 2006 Feb;28(1):35-8. Review. No abstract available.

PMID:
16418691
[PubMed - indexed for MEDLINE]
15.

The management of immunosuppression: the art and the science.

Mancini MC, Cush EM, Launius BK, Brown PA.

Crit Care Nurs Q. 2004 Jan-Mar;27(1):61-4. Review.

PMID:
14974524
[PubMed - indexed for MEDLINE]
16.

The evolution of therapeutic drug monitoring of cyclosporine.

Kahan BD.

Transplant Proc. 2001 Nov-Dec;33(7-8):3086-8. No abstract available.

PMID:
11750326
[PubMed - indexed for MEDLINE]
17.

Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications.

Weimert NA, Derotte M, Alloway RR, Woodle ES, Vinks AA.

Ther Drug Monit. 2007 Apr;29(2):141-9. Review.

PMID:
17417067
[PubMed - indexed for MEDLINE]
18.

Immunosuppressant drugs--the role of therapeutic drug monitoring.

Johnston A, Holt DW.

Br J Clin Pharmacol. 2001;52 Suppl 1:61S-73S. Review. No abstract available.

PMID:
11564054
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Pharmacokinetics and therapeutic drug monitoring of immunosuppressants.

Lindholm A, Säwe J.

Ther Drug Monit. 1995 Dec;17(6):570-3. Review.

PMID:
8588222
[PubMed - indexed for MEDLINE]
20.

Sirolimus: has it gained from experience with older drugs?

Holt DW.

Therapie. 2002 Mar-Apr;57(2):128-32.

PMID:
12185960
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk